Company Earnings UpdateLoblaw (TSX: L) 2Q19 Results: Food Growth Softens Coresight Research July 25, 2019 Executive Summary In 2Q19, ended June 15, Loblaw reported a meaningful weakening of comparable sales growth in its food segment. Food retail comp growth of 0.6% compared to 2.0% in the prior quarter and was well below company-measured food-price inflation of 3.6%. Drug retail comp growth strengthened to 4.0% in 2Q19, from 2.2% in the prior quarter. Management maintained FY19 guidance for positive same-store sales and a stable gross margin in the retail segment. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: Shoptalk Spring 2025: Day Three—Community Building, Earning Loyalty and Enhancing Search Are Top of MindThree Data Points We’re Watching This Week, Week 33: US Consumers’ Tariff PerceptionsOctober 2025 US Retail Sales: Strong Start to the Holiday Quarter Despite Government Shutdown and Dwindling Consumer SentimentEarnings Insights 1Q25: Wrap-Up—Growth Outpaces Declines Across Most Sectors
